Peyman A, Uhlmann E
Hoechst AG, Pharma Research, Frankfurt, Germany.
Biol Chem Hoppe Seyler. 1996 Jan;377(1):67-70. doi: 10.1515/bchm3.1996.377.1.67.
The nuclease resistance of an oligonucleotide sequence that was phosphorothioate (PS)-modified in various positions and patterns was examined. We present a new ¿minimal' protection strategy for antisense oligonucleotides which is a combination of the end-capping technique and the protection of internal pyrimidine residues which are the major sites of endonuclease degradation. This strategy reduces the number of modifications needed to make a nuclease resistant oligonucleotide and therefore should minimize the non-sequence-specific effects that are frequently observed with uniformly modified oligonucleotides.
对在不同位置和模式下进行硫代磷酸酯(PS)修饰的寡核苷酸序列的核酸酶抗性进行了研究。我们提出了一种针对反义寡核苷酸的新的“最小化”保护策略,该策略是封端技术与对作为核酸内切酶降解主要位点的内部嘧啶残基的保护的结合。这种策略减少了制备核酸酶抗性寡核苷酸所需的修饰数量,因此应将均匀修饰的寡核苷酸中经常观察到的非序列特异性效应降至最低。